Tibet Aim Pharm (SZSE:002826) FCF Margin % : 30.69% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tibet Aim Pharm's Free Cash Flow for the three months ended in Mar. 2024 was ¥49.2 Mil. Tibet Aim Pharm's Revenue for the three months ended in Mar. 2024 was ¥160.4 Mil. Therefore, Tibet Aim Pharm's FCF Margin % for the quarter that ended in Mar. 2024 was 30.69%.

As of today, Tibet Aim Pharm's current FCF Yield % is 10.61%.

The historical rank and industry rank for Tibet Aim Pharm's FCF Margin % or its related term are showing as below:

SZSE:002826' s FCF Margin % Range Over the Past 10 Years
Min: -21.29 Med: 4.16 Max: 27.64
Current: 27.64

During the past 10 years, the highest FCF Margin % of Tibet Aim Pharm was 27.64%. The lowest was -21.29%. And the median was 4.16%.

SZSE:002826's FCF Margin % is ranked better than
95.33% of 1028 companies
in the Drug Manufacturers industry
Industry Median: -0.05 vs SZSE:002826: 27.64

Tibet Aim Pharm FCF Margin % Historical Data

The historical data trend for Tibet Aim Pharm's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm FCF Margin % Chart

Tibet Aim Pharm Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-11.13

-20.11

10.51

11.62

7.62

Tibet Aim Pharm Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															18.44	22.40	-0.35	67.38	30.69

Competitive Comparison of Tibet Aim Pharm's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Aim Pharm's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tibet Aim Pharm's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Aim Pharm's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tibet Aim Pharm's FCF Margin % falls into.

Tibet Aim Pharm FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tibet Aim Pharm's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	65.255	/	856.734
	=	7.62 %

Tibet Aim Pharm's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	49.231	/	160.426
	=	30.69 %

Tibet Aim Pharm FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Aim Pharm (SZSE:002826) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000

Website

http://www.emyy.cn

Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.

Tibet Aim Pharm (SZSE:002826) Headlines

No Headlines